Biotest relocates Florida plasma center, ups workforce

By Flora Southey

- Last updated on GMT

iStock/Bet_Noire
iStock/Bet_Noire

Related tags Plasma

Biotest Pharmaceuticals Corporation has relocated its Plasma Center in Pembroke Pines, Florida, US.

The site – used to collect blood for plasma-based therapies – has relocated within the same neighbourhood to Taft Street, Hollywood, Florida and officially opened on July 30.

The Biotest AG-owned firm said it plans to hire additional staff to work at the facility, explaining that it is currently recruiting medical personnel and phlebotomists.

Biotest sites

In January​ this year, Biotest sold its Boca Raton, Florida-based site to ADMA Biologics after the former was issued a complete response letter (CRL) for the facility in July 2016​.

ADMA agreed to resolve the manufacturing issues cited in the CRL, and under the terms of agreement, will gain exclusive rights to Biotest’s plasma-derived approved therapies Nabi-HB and BIVIGAM, the investigational product CIVACIR and $5m (€4.6) worth of inventory.

In addition, German-based Biotest AG announced it would purchase 50% of ADMA’s capital stock and will become owner of two AMA plasma centers in Norcross and Marietta, Georgia, US.

Related topics Upstream Processing Facilities

Related news

Related suppliers

Follow us

Webinars